Positive clinical results set stage for Japan apomorphine filing
This article was originally published in Scrip
Executive Summary
Kyowa Hakko Kirin is moving ahead with preparations for a Japanese approval filing for apomorphine (KW-6500) for the treatment of Parkinson's disease, following positive results from a Phase III clinical trial.